Phil Noland Roberts - 13 Dec 2023 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Chief Technology Officer
Signature
/s/ Sandra Stoneman, Attorney-in-fact
Issuer symbol
IMNM
Transactions as of
13 Dec 2023
Net transactions value
$0
Form type
4
Filing time
15 Dec 2023, 19:28:11 UTC
Previous filing
15 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock option (right to buy) Award $0 +275,000 $0.000000 275,000 13 Dec 2023 Common Stock 275,000 $7.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the options vest on December 8, 2024, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.